These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38251824)

  • 1. Summary Report of a Public Workshop: Case Studies of Multi-Regional Clinical Trial Incorporating Concept of the ICH E17 Guideline.
    Matsushima N; Otsubo Y; Aoi Y; Nakamura R; Kaneko S; Asakawa T; Matsuoka N; Watabe K; Komiyama O; Yamamoto H; Ando Y
    Clin Pharmacol Ther; 2024 May; 115(5):965-970. PubMed ID: 38251824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of estimand framework to the design and analysis of multi-regional clinical trials.
    Niu C; Liang L; Fu R; Zhong W; Wang WWB
    J Biopharm Stat; 2024 Jun; ():1-17. PubMed ID: 38840476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional Differences During the ICH Regulatory Consultation Process Between the EU, US, and Japan.
    Torqui A; Macau AM
    Ther Innov Regul Sci; 2018 Jul; 52(4):438-441. PubMed ID: 29714552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Consistency of Treatment Response Across Regions-the LEADER Trial in Relation to the ICH E17 Guideline.
    Nielsen HK; DeChiaro S; Goldman B
    Front Med (Lausanne); 2021; 8():662775. PubMed ID: 34136501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Points to Consider for Implementation of the ICH E17 Guideline: Learning from Past Multiregional Clinical Trials in Japan.
    Asano K; Aoi Y; Kamada S; Uyama Y; Tohkin M
    Clin Pharmacol Ther; 2021 Jun; 109(6):1555-1563. PubMed ID: 33245786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAPS Workshop Report on ICH M10.
    Booth B; Vazvaei F; Fluhler E; Myler H; Woolf E
    AAPS J; 2019 Dec; 22(1):10. PubMed ID: 31823177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy Comparison for a Schizophrenia and a Dysuria Drug Among East Asian Populations: A Retrospective Analysis Using Multi-regional Clinical Trial Data.
    Sai K; Nakatani E; Iwama Y; Hiraoka S; Tohkin M; Uyama Y; Saito Y
    Ther Innov Regul Sci; 2021 May; 55(3):523-538. PubMed ID: 33393013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical concepts in the planning and evaluation of drug safety from clinical trials in drug development: issues of international harmonization.
    O'Neill RT
    Stat Med; 1995 May 15-30; 14(9-10):117-27. PubMed ID: 7569506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conference Report from the European Bioanalysis Forum Workshop: toward harmonized implementation of the ICH M10 guideline.
    Timmerman P; Barfield M; Cowan K; Ferrari L; Golob M; Goodman J; Kall M; Laurén A; Love I; McDougall S; Nelson R; Pynaert G; Staack RF; Verhaeghe T; White S
    Bioanalysis; 2022 Nov; 14(22):1407-1411. PubMed ID: 36705021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Investigators' Brochure: a comparison of the draft international conference on harmonisation guideline with current Food and Drug Administration requirements.
    Cocchetto DM
    Qual Assur; 1995 Dec; 4(4):240-6. PubMed ID: 8890349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shared Learnings on the New EMA First-in-Human and Early Clinical Trial Guideline: Proceedings From a DIAlogue Session at DIA Europe 2018.
    van der Laan JW; Benson CT; Janssens W; Bos J; Stahl E; Brady JT; Wändel-Liminga U; Corriol-Rohou S; Forster R; Hartmann A; Pertel PE; Robertson SM; Silva-Lima B; Malik RE; Chibout SD
    Ther Innov Regul Sci; 2020 Mar; 54(2):462-467. PubMed ID: 32072587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICH guidelines--implementation of the 3Rs (refinement, reduction, and replacement): incorporating best scientific practices into the regulatory process.
    Ohno Y
    ILAR J; 2002; 43 Suppl():S95-8. PubMed ID: 12388859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harmonization of individual case safety reports transmission requirements among PAHO reference authorities: a review of their current regulation.
    Lomeli-Silva A; Contreras-Salinas H; Barajas-Virgen MY; Romero-Lopez MS; Rodríguez-Herrera LY
    Ther Adv Drug Saf; 2024; 15():20420986241228119. PubMed ID: 38323190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current PMDA Activities for Use of Biomarkers in Drug Evaluation].
    Ishiguro A
    Yakugaku Zasshi; 2015; 135(5):681-4. PubMed ID: 25948301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations and feedback from the European Bioanalysis Forum Workshop: 1 year into ICH M10 - keeping our finger on the pulse.
    Timmerman P; Barfield M; Portabella EB; Calogero S; Cowan K; Faber J; Ferrari L; Golob M; Goodman J; Goodwin L; Gnoth MJ; Hughes R; Ivanova T; Jordan G; Laurén A; Maux D; McDougall S; Milushewa P; Nelson R; Pynaert G; Sklodowski K; Sleigh R; Struwe P; Verhaeghe T; Wheller R; White S; Zeiser K
    Bioanalysis; 2024 Mar; 16(5):259-270. PubMed ID: 38315622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDA Biosimilars Workshop Report (September 27-28, 2018)-Getting It Right the First Time for Biosimilar Marketing Applications.
    Krause S; Lacana E; Welch J; Shapiro M; Downey C; Chung J; Zhou Q; Van Der Plas M; Depatie C; Ingram B; Srebalus-Barnes C; Polozova A; Rellahan B; Choi D; Burdick R; Stangler T; Shacter E
    PDA J Pharm Sci Technol; 2019; 73(4):401-416. PubMed ID: 31004040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICH S1 prospective evaluation study: weight of evidence approach to predict outcome and value of 2-year rat carcinogenicity studies. A report from the regulatory authorities subgroup.
    Bourcier T; McGovern T; Cavaliero T; Ebere G; Nishikawa A; Nishimura J; Ogawa K; Pasanen M; Vespa A; Van der Laan JW
    Front Toxicol; 2024; 6():1353783. PubMed ID: 38665214
    [No Abstract]   [Full Text] [Related]  

  • 19. Simultaneous Global Drug Development and Multiregional Clinical Trials (MRCT): 5 Years After Implementation of ICH E17 Guidelines.
    Singh R; Wang W; Chakravarty A; Wang J; Uyama Y
    Ther Innov Regul Sci; 2024 May; ():. PubMed ID: 38736019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [History of the discussion on ethnic difference at ICH].
    Uchida E
    Yakugaku Zasshi; 2009 Feb; 129(2):213-21. PubMed ID: 19182450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.